Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald F Watts

Showing results (231-240 of 706) with videos related to

Pageof 71
Sort By:
Current Medicinal Chemistry|February 10, 2021
The Yin and Yang of High-density Lipoprotein and Atherosclerotic Cardiovascular Disease: Focusing on Functionality and Cholesterol Efflux to Reframe the HDL HypothesisShiva Ganjali, Gerald F Watts, Maciej Banach, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 18, 2006
Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kineticsDick C Chan, Gerald F Watts, Minh N Nguyen, et al.
Clinical Science (London, England : 1979)|January 6, 2010
Fenofibrate improves endothelial function in the brachial artery and forearm resistance arterioles of statin-treated Type 2 diabetic patientsSandra J Hamilton, Gerard T Chew, Timothy M E Davis, et al.
Journal of Clinical Lipidology|May 28, 2019
Impact of PCSK9 inhibitors on plasma lipoprotein(a) concentrations with or without a background of niacin therapyBruce A Warden, Jessica Minnier, Gerald F Watts, et al.
The American Journal of Clinical Nutrition|July 11, 2006
Factorial study of the effect of n-3 fatty acid supplementation and atorvastatin on the kinetics of HDL apolipoproteins A-I and A-II in men with abdominal obesityDick C Chan, Gerald F Watts, Minh N Nguyen, et al.
The Journal of Clinical Endocrinology and Metabolism|July 23, 2009
Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopyAndrea J Cussons, Gerald F Watts, Trevor A Mori, et al.
The Journal of Clinical Endocrinology and Metabolism|November 15, 2007
Plasma apolipoprotein C-III transport in centrally obese men: associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolismDick C Chan, Minh N Nguyen, Gerald F Watts, et al.
Current Opinion in Endocrinology, Diabetes, and Obesity|December 6, 2022
Lipid-lowering therapies and cardiovascular risk-stratification strategies in adults with type 1 diabetesNick S R Lan, Damon A Bell, Gerald F Watts, et al.
Pharmaceuticals (Basel, Switzerland)|November 24, 2022
Long-Term Efficacy and Safety of Evinacumab in Patients with Homozygous Familial Hypercholesterolemia: Real-World Clinical ExperienceClaudia Stefanutti, Dick C Chan, Serafina Di Giacomo, et al.
Current Opinion in Lipidology|October 15, 2021
Splice correction therapies for familial hypercholesterolemic patients with low-density lipoprotein receptor mutationsCraig S McIntosh, Gerald F Watts, Steve D Wilton, et al.
Pageof 71

Showing results (231-240 of 706) with videos related to

Sort By:
Pageof 71
Current Medicinal Chemistry|February 10, 2021
The Yin and Yang of High-density Lipoprotein and Atherosclerotic Cardiovascular Disease: Focusing on Functionality and Cholesterol Efflux to Reframe the HDL HypothesisShiva Ganjali, Gerald F Watts, Maciej Banach, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 18, 2006
Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kineticsDick C Chan, Gerald F Watts, Minh N Nguyen, et al.
Clinical Science (London, England : 1979)|January 6, 2010
Fenofibrate improves endothelial function in the brachial artery and forearm resistance arterioles of statin-treated Type 2 diabetic patientsSandra J Hamilton, Gerard T Chew, Timothy M E Davis, et al.
Journal of Clinical Lipidology|May 28, 2019
Impact of PCSK9 inhibitors on plasma lipoprotein(a) concentrations with or without a background of niacin therapyBruce A Warden, Jessica Minnier, Gerald F Watts, et al.
The American Journal of Clinical Nutrition|July 11, 2006
Factorial study of the effect of n-3 fatty acid supplementation and atorvastatin on the kinetics of HDL apolipoproteins A-I and A-II in men with abdominal obesityDick C Chan, Gerald F Watts, Minh N Nguyen, et al.
The Journal of Clinical Endocrinology and Metabolism|July 23, 2009
Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopyAndrea J Cussons, Gerald F Watts, Trevor A Mori, et al.
The Journal of Clinical Endocrinology and Metabolism|November 15, 2007
Plasma apolipoprotein C-III transport in centrally obese men: associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolismDick C Chan, Minh N Nguyen, Gerald F Watts, et al.
Current Opinion in Endocrinology, Diabetes, and Obesity|December 6, 2022
Lipid-lowering therapies and cardiovascular risk-stratification strategies in adults with type 1 diabetesNick S R Lan, Damon A Bell, Gerald F Watts, et al.
Pharmaceuticals (Basel, Switzerland)|November 24, 2022
Long-Term Efficacy and Safety of Evinacumab in Patients with Homozygous Familial Hypercholesterolemia: Real-World Clinical ExperienceClaudia Stefanutti, Dick C Chan, Serafina Di Giacomo, et al.
Current Opinion in Lipidology|October 15, 2021
Splice correction therapies for familial hypercholesterolemic patients with low-density lipoprotein receptor mutationsCraig S McIntosh, Gerald F Watts, Steve D Wilton, et al.
Pageof 71